A Study of ZL-1211 in Patients With Advanced Solid Tumor
Clinical trial NCT05065710 · COMPLETED
Trial details
- NCT number
- NCT05065710
- Sponsor
- Zai Biopharmaceutical (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-19
- Primary completion
- 2024-03-09
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.